Status:
COMPLETED
Seroprevalence of SARS CoV 2 Antibodies in Previously Undiagnosed Healthcare Workers
Lead Sponsor:
Mayo Clinic
Conditions:
SARS-CoV 2
COVID-19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to identify healthcare workers with SARS CoV 2 antibodies who have not been previously diagnosed and are presumed COVID-19 negative, then determine the level of immunity i...
Detailed Description
Enrolled participants will complete a survey gauging their level of confidence they will be antibody positive. Participants will then complete serologic testing for SARS CoV 2 IgG antibodies. The stud...
Eligibility Criteria
Inclusion
- Age ≥ 18 years old.
- Mayo Clinic employee in procedural and surgical area.
- Suspected COVID-19 exposure.
- Completed PCR test twice with negative results.
Exclusion
- \- Refusal to participate in this study.
Key Trial Info
Start Date :
May 6 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2020
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04383587
Start Date
May 6 2020
End Date
July 31 2020
Last Update
April 13 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Florida
Jacksonville, Florida, United States, 32224